1067-0299 Screening compound: N-[5-({N'-[(E)-(3-hydroxyphenyl)methylidene]hydrazinecarbonyl}methyl)-1,3,4-thiadiazol-2-yl]benzamide

1067-0299 Screening compound: N-[5-({N'-[(E)-(3-hydroxyphenyl)methylidene]hydrazinecarbonyl}methyl)-1,3,4-thiadiazol-2-yl]benzamide
1067-0299 Screening compound: N-[5-({N'-[(E)-(3-hydroxyphenyl)methylidene]hydrazinecarbonyl}methyl)-1,3,4-thiadiazol-2-yl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 1067-0299
N-[5-({N'-[(E)-(3-hydroxyphenyl)methylidene]hydrazinecarbonyl}methyl)-1,3,4-thiadiazol-2-yl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

1067-0299

Molecular Formula

C18H15N5O3S (C18 H15 N5 O3 S)

Compound Name

N-[5-({N'-[(E)-(3-hydroxyphenyl)methylidene]hydrazinecarbonyl}methyl)-1,3,4-thiadiazol-2-yl]benzamide

IUPAC name

N-[5-({N'-[(E)-(3-hydroxyphenyl)methylidene]hydrazinecarbonyl}methyl)-134-thiadiazol-2-yl]benzamide

SMILES

Oc1cccc(/C=N/NC(Cc2nnc(NC(c3ccccc3)=O)s2)=O)c1

InChI

InChI=1S/C18H15N5O3S/c24-14-8-4-5-12(9-14)11-19-21-15(25)10-16-22-23-18(27-16)20-17(26)13-6-2-1-3-7-13/h1-9,11,24H,10H2,(H,21,25)(H,20,23,26)

InChI Key

MEYYLBYLWUESTG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD00715251

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

381.42

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.489

Distribution Coefficient, logD

2.102

Water Solubility, LogSw

-2.79

Polar Surface Area

100.089

Acid Dissociation Constant (pKa)

7.24

Base Dissociation Constant (pKb)

4.21

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

5.60

1067-0299 in Drug Discovery

Included in Screening Libraries

Dark Chemical Matter Library (18430 compounds)

Eccentric PPI Library (11937 compounds)

Frequent Hitters Library (7624 compounds)

Protein-Protein Interaction Library (218420 compounds)

Carbonic Anhydrase II Library (4939 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Structure:
  • Pool
  • Cyclic compounds
  • Pool
Mechanism of action:
  • PPI modulators
  • PPI modulators
Therapeutical areas:
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with 1067-0299 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 1067-0299?
Check Price and Availability of 1067-0299, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 1067-0299 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 1067-0299
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 1067-0299
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 1067-0299 available by request